2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Roger S. Blumenthal, Pamela B. Morris, Mario Gaudino, Heather M. Johnson, Timothy S. Anderson, Vera A. Bittner, Ron Blankstein, LaPrincess C. Brewer, Leslie Cho, Sarah D. de Ferranti, Eugenia Gianos, Ty J. Gluckman, Kristen Gradney, Ijeoma Isiadinso, Donald M Lloyd-Jones, Joel C. Marrs, Seth S. Martin, Kellie McLain, Laxmi S. Mehta, Samia Mora, Wudeneh Mulugeta, Pradeep Natarajan, Ann Marie Navar, Carl E. Orringer, Tamar S. Polonsky, Harmony R. Reynolds, Joseph J. Saseen, Michael D. Shapiro, Daniel E. Soffer, Sheila Tynes, Chloé Davidson Villavaso, Salim S. Virani, John T. Wilkins, Anand Rohatgi, Samuel M. Kim, Karen P. Alexander, Cheryl Anderson, Catherine P. Benziger, Dave L. Dixon, Daniel Duprez, Keith C. Ferdinand, Anne Carol Goldberg, Parag Joshi, Joshua W. Knowles, Carl (Chip) J. Lavie Jr, Jane A. Linderbaum, John William McEvoy, Anurag Mehta, C. Noel Bairey Merz, Vijay Nambi, Ariela R. Orkaby, Jessica M. Peña,, Robert Rosenson, Janelle Ruisinger, Sigrid E. Sandner, Stacey L. Schott, Laurence (Larry) Sperling, Neil J. Stone, Peter Toth, Adam L. Ware, Seamus Paul Whelton, James Young
Abstract
AIM: The "2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia" retires and replaces the "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol." METHODS: A comprehensive literature search was conducted from October 2024 to December 2024 to identify clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human participants that were published in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. STRUCTURE: The focus of this clinical practice guideline is to address the evaluation, management, and monitoring of individuals with dyslipidemias, including high blood cholesterol, hypertriglyceridemia, and elevated lipoprotein(a).